|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash, cash equivalents and restricted cash | ||||||||
| Trade receivables, net of allowance for expected credit losses of $22.4 and $20.5 as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Inventories | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Current assets held for sale | ||||||||
| Total current assets | ||||||||
| Property, plant and equipment, net | ||||||||
| Operating lease right-of-use-assets, net | ||||||||
| Goodwill | ||||||||
| Intangible assets, net | ||||||||
| Other non-current assets | ||||||||
| Non-current assets held for sale | ||||||||
| Total assets | ||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current Liabilities: | ||||||||
| Current portion of long-term debt | ||||||||
| Trade payables | ||||||||
| Related Party | ||||||||
| Total trade payables | ||||||||
| Accruals and other current liabilities | ||||||||
| Related Party | ||||||||
| Total accruals and other current liabilities | ||||||||
| Current portion of operating lease obligations | ||||||||
| Current liabilities held for sale | ||||||||
| Total current liabilities | ||||||||
| Long-term debt, less current portion | ||||||||
| Operating lease obligations, less current portion | ||||||||
| Deferred income taxes | ||||||||
| Other non-current liabilities | ||||||||
| Non-current liabilities held for sale | ||||||||
| Total liabilities | ||||||||
| Stockholders' Equity: | ||||||||
| Preferred stock, $0.01 and $0.001 par value, nil and $1,000 stated value, 100,000,000 and 250,000 shares authorized at December 31, 2024 and 2023, respectively, nil issued and outstanding at December 31, 2024 and 2023 | ||||||||
| Common stock, $0.01 par value, 900,000,000 shares authorized, 362,464,702 and 363,940,940 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Accumulated other comprehensive loss | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders' equity |
Loading...
